Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation.
Pende D, Falco M, Vitale M, Cantoni C, Vitale C, Munari E, Bertaina A, Moretta F, Del Zotto G, Pietra G, Mingari MC, Locatelli F, Moretta L. · 2019
Read Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation. by Pende D, Falco M, Vitale M, Cantoni C, Vitale C, Munari E, Bertaina A, Moretta F, Del Zotto G, Pietra G, Mingari MC, Locatelli F, Moretta L. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6558367.txt.
Description
Pende and co-authors review killer Ig-like receptors, the switches that govern natural killer cells, writing in Frontiers in Immunology. Part history and part survey, the article honors Alessandro Moretta, whose clone work in the early 1990s uncovered these receptors. KIRs read the HLA class I badges on healthy cells and hold NK cells back; when a tumor drops those badges, the brake releases.
The review covers KIR genetics and their extreme variety, how NK cells are educated to spare the self, and the partner receptors that trigger killing. It then follows the science into the clinic. Donor NK cells in half-matched stem cell transplants can attack leukemia. Checkpoint blockers aimed at KIR, NKG2A or PD-1 open further cancer strategies.
Catalog record
| CREATOR | Pende D, Falco M, Vitale M, Cantoni C, Vitale C, Munari E, Bertaina A, Moretta F, Del Zotto G, Pietra G, Mingari MC, Locatelli F, Moretta L. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 108 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |